_20241010182335_original_image_15.webp)
From early detection of diseases to personalised treatment plans, AI is enhancing the quality of care and improving patient outcomes in ways that were earlier a far cry
Read More
With this collaboration, Centre For Sight, which currently operates 82 centres across 40 cities in 15 states, continues to strengthen its position in the eye care sector
Read More
Cyclosporine Ophthalmic Nanoemulsion employs unique nanoparticle technology to increase tear production in patients with keratoconjunctivitis sicca-related ocular inflammatory disease, offering faster symptom relief for those with suppressed tear formation
Read More
The broader eye care industry has witnessed investments exceeding USD1,050 million in recent years.
Read More
